Max Stanley Chartrand

2.2k total citations · 1 hit paper
16 papers, 1.2k citations indexed

About

Max Stanley Chartrand is a scholar working on Molecular Biology, Oncology and Aquatic Science. According to data from OpenAlex, Max Stanley Chartrand has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Aquatic Science. Recurrent topics in Max Stanley Chartrand's work include CAR-T cell therapy research (6 papers), Virus-based gene therapy research (3 papers) and Ginger and Zingiberaceae research (3 papers). Max Stanley Chartrand is often cited by papers focused on CAR-T cell therapy research (6 papers), Virus-based gene therapy research (3 papers) and Ginger and Zingiberaceae research (3 papers). Max Stanley Chartrand collaborates with scholars based in Iraq, Iran and Malaysia. Max Stanley Chartrand's co-authors include Heshu Sulaiman Rahman, Swee Keong Yeap, Farideh Namvar, Mostafa Jarahian, Faroogh Marofi, Alexei Valerievich Yumashev, Roza Motavalli, Navid Shomali, Yashwant Pathak and Safa Tahmasebi and has published in prestigious journals such as BioMed Research International, International Journal of Nanomedicine and Cancer Science.

In The Last Decade

Max Stanley Chartrand

16 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CAR T cells in solid tumors: challenges and opportunities

2021 395 citations Faroogh Marofi, Roza Motavalli et al. Stem Cell Research & Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max Stanley Chartrand Iraq	11	484	347	301	286	260	16	1.2k
Yu‐Lin Su Taiwan	18	175 0.4×	503 1.4×	257 0.9×	208 0.7×	438 1.7×	33	1.3k
Xuan Wang China	22	290 0.6×	712 2.1×	128 0.4×	199 0.7×	280 1.1×	136	1.5k
Xueying Shi China	20	200 0.4×	307 0.9×	317 1.1×	88 0.3×	180 0.7×	94	1.4k
Rajendra Kumari United Kingdom	19	246 0.5×	370 1.1×	94 0.3×	271 0.9×	177 0.7×	42	1.0k
Meng Jia China	19	262 0.5×	482 1.4×	223 0.7×	130 0.5×	427 1.6×	36	1.4k
Wen-Yu Pan Taiwan	21	200 0.4×	509 1.5×	270 0.9×	182 0.6×	403 1.6×	27	1.3k
Preethi Korangath United States	21	268 0.6×	697 2.0×	152 0.5×	135 0.5×	431 1.7×	42	1.5k
Cheolhee Won South Korea	19	238 0.5×	577 1.7×	197 0.7×	88 0.3×	132 0.5×	33	1.0k
Min Jiao China	20	340 0.7×	718 2.1×	151 0.5×	145 0.5×	207 0.8×	82	1.5k
Xiao Xu China	21	222 0.5×	615 1.8×	164 0.5×	123 0.4×	475 1.8×	56	1.3k

Countries citing papers authored by Max Stanley Chartrand

Since Specialization

Citations

This map shows the geographic impact of Max Stanley Chartrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Stanley Chartrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Stanley Chartrand more than expected).

Fields of papers citing papers by Max Stanley Chartrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Stanley Chartrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Stanley Chartrand. The network helps show where Max Stanley Chartrand may publish in the future.

Co-authorship network of co-authors of Max Stanley Chartrand

This figure shows the co-authorship network connecting the top 25 collaborators of Max Stanley Chartrand. A scholar is included among the top collaborators of Max Stanley Chartrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Stanley Chartrand. Max Stanley Chartrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Marofi, Faroogh, Safa Tahmasebi, Heshu Sulaiman Rahman, et al.. (2021). Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism. Stem Cell Research & Therapy. 12(1). 217–217. 18 indexed citations

Marofi, Faroogh, Safa Tahmasebi, Heshu Sulaiman Rahman, et al.. (2021). Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism. Stem Cell Research & Therapy. 12(1). 443–443. 4 indexed citations

Marofi, Faroogh, Heshu Sulaiman Rahman, Lakshmi Thangavelu, et al.. (2021). Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy. Stem Cell Research & Therapy. 12(1). 200–200. 38 indexed citations

Marofi, Faroogh, Roza Motavalli, В. А. Сафонов, et al.. (2021). CAR T cells in solid tumors: challenges and opportunities. Stem Cell Research & Therapy. 12(1). 81–81. 395 indexed citations breakdown →

Hassanzadeh, Ali, Heshu Sulaiman Rahman, Alexander Markov, et al.. (2021). Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. Stem Cell Research & Therapy. 12(1). 297–297. 137 indexed citations

Marofi, Faroogh, Heshu Sulaiman Rahman, Abduladheem Turki Jalil, et al.. (2021). Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients. Stem Cell Research & Therapy. 12(1). 86 indexed citations

Marofi, Faroogh, Omar F. Abdul‐Rasheed, Heshu Sulaiman Rahman, et al.. (2021). CAR‐NK cell in cancer immunotherapy; A promising frontier. Cancer Science. 112(9). 3427–3436. 100 indexed citations

Rahman, Heshu Sulaiman, Bee Ling Tan, Hemn Hassan Othman, et al.. (2020). An Overview of In Vitro, In Vivo, and Computational Techniques for Cancer‐Associated Angiogenesis Studies. BioMed Research International. 2020(1). 8857428–8857428. 8 indexed citations

Abdul, Ahmad Bustamam, et al.. (2018). Angiogenic Switches Play a Critical Progression in Cancer. Journal of Angiotherapy. 1(2). E048–E057. 2 indexed citations

10.

Rahman, Heshu Sulaiman, et al.. (2018). The Effectiveness of Super Ovulation and Multiple Pregnancies in Sprague Dawley Rat using Morus alba Linn. Fruit. KTH Publication Database DiVA (KTH Royal Institute of Technology). 7(1). 17–26. 3 indexed citations

11.

Rahman, Heshu Sulaiman, et al.. (2015). Antihypercholesterolemic and antioxidant efficacies of zerumbone on the formation, development, and establishment of atherosclerosis in cholesterol-fed rabbits. Drug Design Development and Therapy. 9. 4173–4173. 15 indexed citations

12.

Namvar, Farideh, Heshu Sulaiman Rahman, Rosfarizan Mohamad, et al.. (2015). Cytotoxic Effects of Biosynthesized Zinc Oxide Nanoparticles on Murine Cell Lines. Evidence-based Complementary and Alternative Medicine. 2015. 1–11. 118 indexed citations

13.

Namvar, Farideh, Heshu Sulaiman Rahman, Rosfarizan Mohamad, et al.. (2015). Apoptosis Induction in Human Leukemia Cell Lines by Gold Nanoparticles Synthesized Using the Green Biosynthetic Approach. Journal of Nanomaterials. 2015(1). 28 indexed citations

14.

Namvar, Farideh, Javad Baharara, Elaheh Amini, et al.. (2014). Cytotoxic effect of magnetic iron oxide nanoparticles synthesized via seaweed aqueous extract. International Journal of Nanomedicine. 9. 2479–2479. 210 indexed citations

15.

Rahman, Heshu Sulaiman, Rasedee Abdullah, Swee Keong Yeap, et al.. (2014). Biomedical Properties of a Natural Dietary Plant Metabolite, Zerumbone, in Cancer Therapy and Chemoprevention Trials. BioMed Research International. 2014. 1–20. 75 indexed citations

16.

Rahman, Heshu Sulaiman, Rasedee Abdullah, Max Stanley Chartrand, et al.. (2014). Zerumbone Induces G2/M Cell Cycle Arrest and Apoptosis via Mitochondrial Pathway in Jurkat cell Line. Natural Product Communications. 9(9). 1237–42. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact